Hong-Kyu Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hong-Kyu Kim has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
- Wonshik Han
Division of Breast Surgery, Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
27 shared publications - Han-Byoel Lee
Seoul National University College of Medicine
25 shared publications - Hyeong-Gon Moon
Department of Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
22 shared publications - Jong-Ho Cheun
Department of Surgery, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea
18 shared publications - Ji Gwang Jung
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
17 shared publications - Eun-Shin Lee
Department of Surgery, Korea University Hospital, Korea University College of Medicine, Seoul, Korea
13 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11)
The cumulative risk of contralateral breast cancer (CBC) in BRCA1/2 carriers is remarkably higher than in non-carriers. This study aimed to investigate the
- 9 April 2026
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Open AccessContributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11)
The cumulative risk of contralateral breast cancer (CBC) in BRCA1/2 carriers is remarkably higher than in non-carriers. This study aimed to investigate the
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Breast Cancer
- Vol. 29 (2) , 154-162
Clinical Implications of the Langer’s Axillary Arch Muscle in Breast Cancer Patients
Kang E, et al. J Breast Cancer. 2026 ;29:e16. https://doi.org/10.4048/jbc.2025.0264
- 1 January 2026
- Published by XMLink in Journal of Breast Cancer
- Vol. 29 (2) , 154-162
Open AccessClinical Implications of the Langer’s Axillary Arch Muscle in Breast Cancer Patients
Kang E, et al. J Breast Cancer. 2026 ;29:e16. https://doi.org/10.4048/jbc.2025.0264
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Tables and Figures from Triple-Negative Breast Cancer-Derived Extracellular Vesicles Promote a Hepatic Premetastatic Niche via a Cascade of Microenvironment Remodeling
Supplementary Table 1. Information about patients derived xenograft models and derived patient.Supplementary Table 2. Ontology of differentially expressed genes in metastasis-harboring liver of PDX models.Supplementary Table 3. Differentially expressed genes in liver and lung of metastasis-harboring PDX models.Supplementary Table 4. Human ratio in lung and liver of additional PDX models identified by RNA sequencing.Supplementary Table 5. Gene ontology of co-expressed genes with Cx3cr1 in liver of PDX models identified by RNA sequencing.Supplementary Table 6. Top ranked genes having significant correlation with Cx3cr1 in liver of PDX models identified by RNA sequencing.Supplementary Table 7. Demographic and clinical characteristics of all patients.Supplementary Table 8. Information about used primer sequences for quantitative real-time PCRSupplementary Figure 1. Liver and lung H&E staining pictures of eight nonmetastatic PDX models a. Microscopic images of non-metastasis harboring PDX mouse model's liver (left) and lung (right) taken at 400x magnification.Supplementary Figure 2. Immunohistochemistry about CX3CR1 in liver and lung of breast cancer metastasis patients.Supplementary Figure 3. Hepatic metastasis after four weeks after orthotopic injection of 4T1 breast cancer cells identified by H&E staining.Supplementary Figure 4. Identification of pre-metastatic niche in liver tissues of 4T1 bearing mice a. mRNA expression of inflammation associated genes identified by real-time PCR in liver tissues of 4T1 bearing mice.Supplementary Figure 5. Identification of CX3CR1 positive cell population.Supplementary Figure 6. FACS analysis with anti-CX3CR1 of Raw264.7 macrophage cell lines.Supplementary Figure 7. Trans-well migration assay of BMDM with or without CX3CL1.Supplementary Figure 8. Mmp9 mRNA expression having significant correlation with Cx3cr1 mRNA expression in liver of PDX models.Supplementary Figure 9. MMP9 expression of macrophages with CX3CL1 treatment.Supplementary Figure 10. Signaling pathway of CX3CL1 treated macrophages.Supplementary Figure 11. Splenic injection of 4T1 cells inducing hepatic metastasis within two weeks in most cases.Supplementary Figure 12. mRNA expression about Cx3cr1 and Mmp9 in liver of vehicle or AZD8797 treated BALB/C mice identified by real-time PCR.Supplementary Figure 13. Correlation plot of Tnfa and Cx3cr1 mRNA expression in liver and lung of PDX models.Supplementary Figure 14. EVs isolation of CD63-mRuby-4T1.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables and Figures from Triple-Negative Breast Cancer-Derived Extracellular Vesicles Promote a Hepatic Premetastatic Niche via a Cascade of Microenvironment Remodeling
Supplementary Table 1. Information about patients derived xenograft models and derived patient.Supplementary Table 2. Ontology of differentially expressed genes in metastasis-harboring liver of PDX models.Supplementary Table 3. Differentially expressed genes in liver and lung of metastasis-harboring PDX models.Supplementary Table 4. Human ratio in lung and liver of additional PDX models identified by RNA sequencing.Supplementary Table 5. Gene ontology of co-expressed genes with Cx3cr1 in liver of PDX models identified by RNA sequencing.Supplementary Table 6. Top ranked genes having significant correlation with Cx3cr1 in liver of PDX models identified by RNA sequencing.Supplementary Table 7. Demographic and clinical characteristics of all patients.Supplementary Table 8. Information about used primer sequences for quantitative real-time PCRSupplementary Figure 1. Liver and lung H&E staining pictures of eight nonmetastatic PDX models a. Microscopic images of non-metastasis harboring PDX mouse model's liver (left) and lung (right) taken at 400x magnification.Supplementary Figure 2. Immunohistochemistry about CX3CR1 in liver and lung of breast cancer metastasis patients.Supplementary Figure 3. Hepatic metastasis after four weeks after orthotopic injection of 4T1 breast cancer cells identified by H&E staining.Supplementary Figure 4. Identification of pre-metastatic niche in liver tissues of 4T1 bearing mice a. mRNA expression of inflammation associated genes identified by real-time PCR in liver tissues of 4T1 bearing mice.Supplementary Figure 5. Identification of CX3CR1 positive cell population.Supplementary Figure 6. FACS analysis with anti-CX3CR1 of Raw264.7 macrophage cell lines.Supplementary Figure 7. Trans-well migration assay of BMDM with or without CX3CL1.Supplementary Figure 8. Mmp9 mRNA expression having significant correlation with Cx3cr1 mRNA expression in liver of PDX models.Supplementary Figure 9. MMP9 expression of macrophages with CX3CL1 treatment.Supplementary Figure 10. Signaling pathway of CX3CL1 treated macrophages.Supplementary Figure 11. Splenic injection of 4T1 cells inducing hepatic metastasis within two weeks in most cases.Supplementary Figure 12. mRNA expression about Cx3cr1 and Mmp9 in liver of vehicle or AZD8797 treated BALB/C mice identified by real-time PCR.Supplementary Figure 13. Correlation plot of Tnfa and Cx3cr1 mRNA expression in liver and lung of PDX models.Supplementary Figure 14. EVs isolation of CD63-mRuby-4T1.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Triple-Negative Breast Cancer-Derived Extracellular Vesicles Promote a Hepatic Premetastatic Niche via a Cascade of Microenvironment Remodeling
Patients with triple-negative breast cancer (TNBC) often develop metastases in visceral organs including the liver, but the detailed molecular mechanisms of TNBC liver metastasis is not clearly understood. In this study, we tried to dissect the process of premetastatic niche formation in the liver by using patient-derived xenograft (PDX) models of TNBC with different metastatic propensity. RNA sequencing of TNBC PDX models that successfully metastasized to liver showed upregulation of the Cx3cr1 gene in the liver microenvironment. In syngeneic breast cancer models, the Cx3cr1 upregulation in liver preceded the development of cancer cell metastasis and was the result of recruitment of CX3CR1-expressing macrophages. The recruitment was induced by the CX3CL1 production from the liver endothelial cells and this CX3CL1–CX3CR1 signaling in the premetastatic niche resulted in upregulation of MMP9 that promoted macrophage migration and cancer cell invasion. In addition, our data suggest that the extracellular vesicles derived from the breast cancer cells induced the TNFα expression in liver, which leads to the CX3CL1 upregulation. Lastly, the plasma CX3CL1 levels in 155 patients with breast cancer were significantly associated with development of liver metastasis.Implications:Our data provides previously unknown cascades regarding the molecular education of premetastatic niche in liver for TNBC.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Triple-Negative Breast Cancer-Derived Extracellular Vesicles Promote a Hepatic Premetastatic Niche via a Cascade of Microenvironment Remodeling
Patients with triple-negative breast cancer (TNBC) often develop metastases in visceral organs including the liver, but the detailed molecular mechanisms of TNBC liver metastasis is not clearly understood. In this study, we tried to dissect the process of premetastatic niche formation in the liver by using patient-derived xenograft (PDX) models of TNBC with different metastatic propensity. RNA sequencing of TNBC PDX models that successfully metastasized to liver showed upregulation of the Cx3cr1 gene in the liver microenvironment. In syngeneic breast cancer models, the Cx3cr1 upregulation in liver preceded the development of cancer cell metastasis and was the result of recruitment of CX3CR1-expressing macrophages. The recruitment was induced by the CX3CL1 production from the liver endothelial cells and this CX3CL1–CX3CR1 signaling in the premetastatic niche resulted in upregulation of MMP9 that promoted macrophage migration and cancer cell invasion. In addition, our data suggest that the extracellular vesicles derived from the breast cancer cells induced the TNFα expression in liver, which leads to the CX3CL1 upregulation. Lastly, the plasma CX3CL1 levels in 155 patients with breast cancer were significantly associated with development of liver metastasis.Implications:Our data provides previously unknown cascades regarding the molecular education of premetastatic niche in liver for TNBC.
- Open Access
- 3 November 2025
- Published by Springer Nature in Breast Cancer Research
- Vol. 27 (1) , 1-9
Differential prognostic significance of tumor size and node in invasive lobular carcinoma of breast
Invasive lobular carcinoma (ILC) is the second most common histological type of breast cancer. Despite its distinct clinical and pathological characteristics, ILC shares the same prognostic classification system and adjuvant treatment strategies as invasive ductal carcinoma (IDC). We reviewed the data of the 16,365 IDC and ILC patients who were treated between 2005 and 2022 at Seoul National University Hospital (SNUH). Also, we conducted a parallel analysis using the data of 247,290 IDC and ILC treated between 2010 and 2015 from the surveillance, epidemiology, and end results (SEER) database. ILC patients were older at diagnosis, had larger tumors, and ILC tumors were predominantly HR-positive/HER2-negative. ILC exhibited unique prognostic implications of anatomic features. Unlike in IDC, the tumor size and nodal status showed differential prognostic impact on survival in ILC. While there was no significant survival difference for different T stages in ILC patients, the prognostic impact of nodal involvement was more pronounced for ILC in the SNUH dataset. Similar survival implication of tumor size and nodal involvement was observed for the ILC cases in the SEER dataset. In ILC, tumor size may not be as strong a predictor of survival as in IDC, while advanced nodal involvement carries a particularly high risk for breast cancer-specific mortality.
- 3 November 2025
- Published by Springer Nature in Breast Cancer Research
- Vol. 27 (1) , 1-9
Open AccessDifferential prognostic significance of tumor size and node in invasive lobular carcinoma of breast
Invasive lobular carcinoma (ILC) is the second most common histological type of breast cancer. Despite its distinct clinical and pathological characteristics, ILC shares the same prognostic classification system and adjuvant treatment strategies as invasive ductal carcinoma (IDC). We reviewed the data of the 16,365 IDC and ILC patients who were treated between 2005 and 2022 at Seoul National University Hospital (SNUH). Also, we conducted a parallel analysis using the data of 247,290 IDC and ILC treated between 2010 and 2015 from the surveillance, epidemiology, and end results (SEER) database. ILC patients were older at diagnosis, had larger tumors, and ILC tumors were predominantly HR-positive/HER2-negative. ILC exhibited unique prognostic implications of anatomic features. Unlike in IDC, the tumor size and nodal status showed differential prognostic impact on survival in ILC. While there was no significant survival difference for different T stages in ILC patients, the prognostic impact of nodal involvement was more pronounced for ILC in the SNUH dataset. Similar survival implication of tumor size and nodal involvement was observed for the ILC cases in the SEER dataset. In ILC, tumor size may not be as strong a predictor of survival as in IDC, while advanced nodal involvement carries a particularly high risk for breast cancer-specific mortality.
- 1 October 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (1) , e250439
Preoperative Breast MRI and Survival Outcomes in Women 50 Years or Younger with Breast Cancer
Undergoing preoperative MRI was associated with reduced risk of ipsilateral in-breast recurrence in patients 50 years or younger with breast cancer, with the greatest benefit observed in those with hormone receptor–negative cancers.
- 1 October 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (1) , e250439
Preoperative Breast MRI and Survival Outcomes in Women 50 Years or Younger with Breast Cancer
Undergoing preoperative MRI was associated with reduced risk of ipsilateral in-breast recurrence in patients 50 years or younger with breast cancer, with the greatest benefit observed in those with hormone receptor–negative cancers.
- Open Access
- 9 June 2025
- Published by Elsevier in The Breast
- Vol. 82, 104515
Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort
- 9 June 2025
- Published by Elsevier in The Breast
- Vol. 82, 104515
Open AccessBody mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort
- 1 April 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 315 (1) , e242955
Breast Cancer Detection with Standalone AI versus Radiologist Interpretation of Unilateral Surveillance Mammography after Mastectomy
Standalone artificial intelligence (AI) could detect contralateral breast cancers in patients treated with unilateral mastectomy, showing higher cancer detection rates and sensitivity than radiologists without AI assistance.
- 1 April 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 315 (1) , e242955
Breast Cancer Detection with Standalone AI versus Radiologist Interpretation of Unilateral Surveillance Mammography after Mastectomy
Standalone artificial intelligence (AI) could detect contralateral breast cancers in patients treated with unilateral mastectomy, showing higher cancer detection rates and sensitivity than radiologists without AI assistance.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Breast Cancer
- Vol. 28 (3) , 171-179
Trends and Perspectives in Oncoplastic Breast Surgery: Findings From a Web-Based Survey With the Korean Breast Cancer Society
Lee J, et al. J Breast Cancer. 2025 Apr;28:e13. https://doi.org/10.4048/jbc.2024.0285
- 1 January 2025
- Published by XMLink in Journal of Breast Cancer
- Vol. 28 (3) , 171-179
Open AccessTrends and Perspectives in Oncoplastic Breast Surgery: Findings From a Web-Based Survey With the Korean Breast Cancer Society
Lee J, et al. J Breast Cancer. 2025 Apr;28:e13. https://doi.org/10.4048/jbc.2024.0285
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Breast Cancer
- Vol. 28 (1) , 48-49
Reply to “Letter to the Editor: Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer”
Byeon J, et al. J Breast Cancer. 2025 Feb;28:e3. https://doi.org/10.4048/jbc.2024.0299
- 1 January 2025
- Published by XMLink in Journal of Breast Cancer
- Vol. 28 (1) , 48-49
Open AccessReply to “Letter to the Editor: Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer”
Byeon J, et al. J Breast Cancer. 2025 Feb;28:e3. https://doi.org/10.4048/jbc.2024.0299